Curcumin-phosphatidylcholine for Tinnitus, Subjective

Phase-Based Progress Estimates
Tinnitus, Subjective+1 More
Curcumin-phosphatidylcholine - Biological
All Sexes
What conditions do you have?

Study Summary

This trial will study whether highly bioavailable curcumin can help to reduce tinnitus symptoms.

Eligible Conditions
  • Tinnitus, Subjective

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Tinnitus, Subjective

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: Evaluate at the beginning of the trial and at the end of the 30 day treatment period.

Day 30
Determine Changes in the Tinnitus Handicap Inventory (THI)
Mean change on the Tinnitus Functional Index (TFI)

Trial Safety

Safety Progress

1 of 3

Other trials for Tinnitus, Subjective

Trial Design

2 Treatment Groups

Treatment Group
1 of 2
Placebo Group
1 of 2
Experimental Treatment
Non-Treatment Group

110 Total Participants · 2 Treatment Groups

Primary Treatment: Curcumin-phosphatidylcholine · Has Placebo Group · N/A

Treatment Group
Experimental Group · 1 Intervention: Curcumin-phosphatidylcholine · Intervention Types: Biological
Placebo Group
PlaceboComparator Group · 1 Intervention: Placebo capsule · Intervention Types: Biological

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: evaluate at the beginning of the trial and at the end of the 30 day treatment period.

Who is running the clinical trial?

Ascension South East MichiganLead Sponsor
17 Previous Clinical Trials
3,080 Total Patients Enrolled
Seilish Babu, MDPrincipal InvestigatorMichigan Ear Institute
1 Previous Clinical Trials
6 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 21st, 2021

Last Reviewed: October 11th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
New York4.9%
How old are they?
18 - 6578.3%
< 184.3%
What site did they apply to?
Michigan Ear Institute100.0%
What portion of applicants met pre-screening criteria?
Met criteria93.9%
Did not meet criteria6.1%